Cargando…
Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects
Bone defects of orthopedic trauma remain a challenge in clinical practice. Regarding bone void fillers, besides the well-known osteoconductivity of most bone substitutes, osteoinductivity has also been gaining attention in recent years. It is known that stromal cell-derived factor-1 (SDF-1) can recr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306626/ https://www.ncbi.nlm.nih.gov/pubmed/34357232 http://dx.doi.org/10.3390/mi12070822 |
_version_ | 1783727855734095872 |
---|---|
author | Chang, Yun-Liang Hsieh, Chia-Ying Yeh, Chao-Yuan Chang, Chih-Hao Lin, Feng-Huei |
author_facet | Chang, Yun-Liang Hsieh, Chia-Ying Yeh, Chao-Yuan Chang, Chih-Hao Lin, Feng-Huei |
author_sort | Chang, Yun-Liang |
collection | PubMed |
description | Bone defects of orthopedic trauma remain a challenge in clinical practice. Regarding bone void fillers, besides the well-known osteoconductivity of most bone substitutes, osteoinductivity has also been gaining attention in recent years. It is known that stromal cell-derived factor-1 (SDF-1) can recruit mesenchymal stem cells (MSCs) in certain circumstances, which may also play an important role in bone regeneration. In this study, we fabricated a gelatin/hyaluronate (Gel/HA) copolymer mixed with hydroxyapatite (HAP) and SDF-1 to try and enhance bone regeneration in a bone defect model. After material characterization, these Gel/HA–HAP and Gel/HA–HAP–SDF-1 composites were tested for their biocompatibility and ability to recruit MSCs in vitro. A femoral condyle bone defect model of rats was used for in vivo studies. For the assessment of bone healing, micro-CT analysis, second harmonic generation (SHG) imaging, and histology studies were performed. As a result, the Gel/HA–HAP composites showed no systemic toxicity to rats. Gel/HA–HAP composite groups both showed better bone generation compared with the control group in an animal study, and the composite with the SDF-1 group even showed a trend of faster bone growth compared with the composite without SDF-1 group. In conclusion, in the management of traumatic bone defects, Gel/HA–HAP–SDF-1 composites can be a feasible material for use as bone void fillers. |
format | Online Article Text |
id | pubmed-8306626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83066262021-07-25 Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects Chang, Yun-Liang Hsieh, Chia-Ying Yeh, Chao-Yuan Chang, Chih-Hao Lin, Feng-Huei Micromachines (Basel) Article Bone defects of orthopedic trauma remain a challenge in clinical practice. Regarding bone void fillers, besides the well-known osteoconductivity of most bone substitutes, osteoinductivity has also been gaining attention in recent years. It is known that stromal cell-derived factor-1 (SDF-1) can recruit mesenchymal stem cells (MSCs) in certain circumstances, which may also play an important role in bone regeneration. In this study, we fabricated a gelatin/hyaluronate (Gel/HA) copolymer mixed with hydroxyapatite (HAP) and SDF-1 to try and enhance bone regeneration in a bone defect model. After material characterization, these Gel/HA–HAP and Gel/HA–HAP–SDF-1 composites were tested for their biocompatibility and ability to recruit MSCs in vitro. A femoral condyle bone defect model of rats was used for in vivo studies. For the assessment of bone healing, micro-CT analysis, second harmonic generation (SHG) imaging, and histology studies were performed. As a result, the Gel/HA–HAP composites showed no systemic toxicity to rats. Gel/HA–HAP composite groups both showed better bone generation compared with the control group in an animal study, and the composite with the SDF-1 group even showed a trend of faster bone growth compared with the composite without SDF-1 group. In conclusion, in the management of traumatic bone defects, Gel/HA–HAP–SDF-1 composites can be a feasible material for use as bone void fillers. MDPI 2021-07-14 /pmc/articles/PMC8306626/ /pubmed/34357232 http://dx.doi.org/10.3390/mi12070822 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chang, Yun-Liang Hsieh, Chia-Ying Yeh, Chao-Yuan Chang, Chih-Hao Lin, Feng-Huei Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects |
title | Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects |
title_full | Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects |
title_fullStr | Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects |
title_full_unstemmed | Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects |
title_short | Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects |
title_sort | fabrication of stromal cell-derived factor-1 contained in gelatin/hyaluronate copolymer mixed with hydroxyapatite for use in traumatic bone defects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306626/ https://www.ncbi.nlm.nih.gov/pubmed/34357232 http://dx.doi.org/10.3390/mi12070822 |
work_keys_str_mv | AT changyunliang fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects AT hsiehchiaying fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects AT yehchaoyuan fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects AT changchihhao fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects AT linfenghuei fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects |